Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
1.250
+0.020 (1.63%)
At close: Mar 9, 2026, 4:00 PM EDT
1.230
-0.020 (-1.58%)
After-hours: Mar 9, 2026, 7:58 PM EDT
Immunic Market Cap
Immunic has a market cap or net worth of $163.08 million as of March 9, 2026. Its market cap has increased by 53.43% in one year.
Market Cap
163.08M
Enterprise Value
148.18M
1-Year Change
53.43%
Ranking
Category
Stock Price
$1.25
Market Cap Chart
Since April 15, 2019, Immunic's market cap has decreased from $243.61M to $163.08M, a decrease of -33.06%. That is a compound annual growth rate of -5.65%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sagimet Biosciences | 175.94M |
| Tonix Pharmaceuticals Holding | 172.08M |
| Caribou Biosciences | 170.11M |
| Jyong Biotech | 166.10M |
| Karyopharm Therapeutics | 160.88M |
| Milestone Pharmaceuticals | 160.50M |
| Rani Therapeutics Holdings | 157.98M |
| Fate Therapeutics | 154.63M |